Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 17.00 TWD
Change Today +0.95 / 5.92%
Volume 471.0K
As of 2:37 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

maxigen biotech inc (1783) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/2/14 - 54.90
52 Week Low
08/25/15 - 15.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MAXIGEN BIOTECH INC (1783)

Related News

No related news articles were found.

maxigen biotech inc (1783) Related Businessweek News

No Related Businessweek News Found

maxigen biotech inc (1783) Details

Maxigen Biotech Inc. is engaged in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. The company offers medical devices, such as Formagraft bone graft substitute, Foramic bone graft substitute, and ArtiAid intra-articular injection for use in orthopedic area; ViscAid, an ophthalmic viscosurgical device for application in ophthalmic area; GingivAid collagen dental grafts, FormaAid collagen membranes, and Foramic bone graft substitutes for use in dental area; and SurgiAid collagen wound dressing for dental and wound dressing applications. It also provides skincare products, including mask materials and designs; and make up remover, cleansing, exfoliating, toner, essence, nutritious cream, men’s care, sunscreen, body care, hand/foot care, and special care products. In addition, the company offers facial soothing skin reinvigorating, herbal whitening, potent anti-acne, and ageless lifting collections under the BIOFLASH brand name; and crystal peptide collection under the Dr. Neo brand name. Maxigen Biotech Inc. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

Founded in 1998

maxigen biotech inc (1783) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

maxigen biotech inc (1783) Key Developments

Maxigen Biotech Inc., Annual General Meeting, Jun 22, 2015

Maxigen Biotech Inc., Annual General Meeting, Jun 22, 2015.

Maxigen Biotech Inc., Annual General Meeting, Jun 16, 2014

Maxigen Biotech Inc., Annual General Meeting, Jun 16, 2014.

Maxigen Biotech Inc.(TSEC:1783) added to Taiwan TAIEX Index

Maxigen Biotech Inc. will be added to the Taiwan TAIEX Index.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1783:TT 17.00 TWD +0.95

1783 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1783.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1783 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAXIGEN BIOTECH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at